Identification of the receptor component of the IκBα–ubiquitin ligase (original) (raw)

Nature volume 396, pages 590–594 (1998)Cite this article

Abstract

NF-κB, a ubiquitous, inducible transcription factor involved in immune, inflammatory, stress and developmental processes, is retained in a latent form in the cytoplasm of non-stimulated cells by inhibitory molecules, IκBs1,2,3. Its activation is a paradigm for a signal-transduction cascade that integrates an inducible kinase and the ubiquitin–proteasome system to eliminate inhibitory regulators. Here we isolate the pIκBα–ubiquitin ligase (pIκBα-E3) that attaches ubiquitin, a small protein which marks other proteins for degradation by the proteasome system, to the phosphorylated NF-κB inhibitor pIκBα. Taking advantage of its high affinity to pIκBα, we isolate this ligase from HeLa cells by single-step immunoaffinity purification. Using nanoelectrospray mass spectrometry, we identify the specific component of the ligase that recognizes the pIκBα degradation motif as an F-box/WD-domainprotein belonging to a recently distinguished family of β-TrCP/Slimb proteins. This component, which we denote E3RSIκB (pIκBα-E3 receptor subunit), binds specifically to pIκBα and promotes its in vitro ubiquitination in the presence of two other ubiquitin-system enzymes, E1 and UBC5C, one of many known E2 enzymes. An F-box-deletion mutant of E3RSIκB, which tightly binds pIκBα but does not support its ubiquitination, acts in vivo as a dominant-negative molecule, inhibiting the degradation of pIκBα and consequently NF-κB activation. E3RSIκB represents a family of receptor proteins that are core components of a class of ubiquitin ligases. When these receptor components recognize their specific ligand, which is a conserved, phosphorylation-based sequence motif, they target regulatory proteins containing this motif for proteasomal degradation.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Baldwin, A. S. J The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649–683 (1996).
    Article CAS Google Scholar
  2. May, M. J. & Ghosh, S. Signal transduction through NF-κB. Immunol. Today 19, 80–88 (1998).
    Article CAS Google Scholar
  3. Baeuerle, P. A. & Baltimore, D. NF-κB: ten years after. Cell 87, 13–20 (1996).
    Article CAS Google Scholar
  4. DiDonato, J. A., Hayakawa, M., Rothwarf, D. M., Zandi, E. & Karin, M. Acytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388, 548–554 (1997).
    Article ADS CAS Google Scholar
  5. Regnier, C. H. et al. Identification and characterization of an IκB kinase. Cell 90, 373–383 (1997).
    Article CAS Google Scholar
  6. Mercurio, F. et al. IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science 278, 860–866 (1997).
    Article ADS CAS Google Scholar
  7. Woronicz, J. D., Gao, X., Cao, Z., Rothe, M. & Goeddel, D. V. IκB kinase-β: NF-κB activation and complex formation with IκB kinase-α and NIK. Science 278, 866–869 (1997).
    Article ADS CAS Google Scholar
  8. Zandi, E., Rothwarf, D. M., Delhase, M., Hayakawa, M. & Karin, M. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell 91, 243–252 (1997).
    Article CAS Google Scholar
  9. Yamaoka, S. et al. Complementation cloning of NEMO, a component of the IκB kinase complex essential for NF-κB activation. Cell 93, 1231–1240 (1998).
    Article CAS Google Scholar
  10. Rothwarf, D. M., Zandi, E., Natoli, G. & Karin, M. IKK-γ is an essential regulatory subunit of the IκB kinase complex. Nature 395, 297–300 (1998).
    Article ADS CAS Google Scholar
  11. Cohen, L., Henzel, W. J. & Baeuerle, P. A. IKAP is a scaffold protein of the IκB kinase complex. Nature 395, 292–296 (1998).
    Article ADS CAS Google Scholar
  12. Chen, Z. et al. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Genes Dev. 9, 1586–1597 (1995).
    Article CAS Google Scholar
  13. Alkalay, I. et al. Stimulation-dependent IκBα phosphorylation marks the NF-κB inhibitor for degradation via the ubiquitin-proteasome pathway. Proc. Natl Acad. Sci. USA 92, 10599–10603 (1995).
    Article ADS CAS Google Scholar
  14. Yaron, A. et al. Inhibition of NF-κB cellular function via specific targeting of the IκB-ubiquitin ligase. EMBO J. 16, 6486–6494 (1997).
    Article CAS Google Scholar
  15. Wilm, M. et al. Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry. Nature 379, 466–469 (1996).
    Article ADS CAS Google Scholar
  16. Margottin, F. et al. Anovel human WD protein, h-βTrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol. Cell 1, 565–574 (1998).
    Article CAS Google Scholar
  17. Shevchenko, A. et al. Rapid de novo peptide sequencing by a combination of nanoelectrospray, isotopic labeling and a quadrupole/time-of-flight mass spectrometer. Rapid Commun. Mass Spectrom. 11, 1015–1024 (1997).
    Article ADS CAS Google Scholar
  18. Hershko, A. & Ciechanover, A. The ubiquitin system. Annu. Rev. Biochem. 67, 425–479 (1998).
    Article CAS Google Scholar
  19. Hochstrasser, M. Ubiquitin-dependent protein degradation. Annu. Rev. Genet. 30, 405–439 (1996).
    Article CAS Google Scholar
  20. Varshavsky, A. The ubiquitin system. Trends Biochem. Sci. 22, 383–387 (1997).
    Article CAS Google Scholar
  21. Paul, M. & Jabbar, M. A. Phosphorylation of both phosphoacceptor sites in the HIV-1 Vpu cytoplasmic domain is essential for Vpu-mediated ER degradation of CD4. Virology 232, 207–216 (1997).
    Article CAS Google Scholar
  22. Jiang, J. & Struhl, G. Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb. Nature 391, 493–496 (1998).
    Article ADS CAS Google Scholar
  23. Skowyra, D., Craig, K. L., Tyers, M., Elledge, S. J. & Harper, J. W. F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex. Cell 91, 209–219 (1997).
    Article CAS Google Scholar
  24. Feldman, R. M., Correll, C. C., Kaplan, K. B. & Deshaies, R. J. Acomplex of Cdc4p, Skp1p, and Cdc53p/cullin catalyzes ubiquitination of the phosphorylated CDK inhibitor Sic1p. Cell 91, 221–230 (1997).
    Article CAS Google Scholar
  25. Patton, E. E. et al. Cdc53 is a scaffold protein for multiple Cdc34/Skp1/F-box protein complexes that regulate cell division and methionine biosynthesis in yeast. Genes Dev. 12, 692–705 (1998).
    Article CAS Google Scholar
  26. Elledge, S. J. & Harper, J. W. The role of protein stability in the cell cycle and cancer. Biochim. Biophys. Acta 1377, M61–M70 (1998).
    CAS PubMed Google Scholar
  27. Jensen, J. P., Bates, P. W., Yang, M., Vierstra, R. D. & Weissman, A. M. Identification of a family of closely related human ubiquitin conjugating enzymes. J. Biol. Chem. 270, 30408–30414 (1995).
    Article CAS Google Scholar

Download references

Acknowledgements

We thank I. Alkalay for her invaluable role in developing many of the assays used in this work, A. Ciechanover for his support and advice in the early phases of the project, and A. Mahler and A. Bar-Sinai for comments on the manuscript. This research was supported by grants from the Israel Science Foundation funded by the Israel Academy for Sciences and Humanities-Centers of Excellence Program, the German–Israel Foundation for Scientific Research and Development, and Signal Pharmaceuticals Inc. (San Diego).

Author information

Author notes

  1. Avraham Yaron and Ada Hatzubai: These authors contributed equally to this work

Authors and Affiliations

  1. The Lautenberg Center for Immunology, The Hebrew University-Hadassah Medical School, Jerusalem, 91120, Israel
    Avraham Yaron, Ada Hatzubai, Matti Davis, Iris Lavon, Sharon Amit & Yinon Ben-Neriah
  2. Signal Pharmaceuticals Inc., San Diego, 92121, California, USA
    Anthony M. Manning & Frank Mercurio
  3. Protana A/S, Staermosegaardsvej, DK-5230 16, Odense M, Denmark
    Jens S. Andersen & Matthias Mann

Authors

  1. Avraham Yaron
    You can also search for this author inPubMed Google Scholar
  2. Ada Hatzubai
    You can also search for this author inPubMed Google Scholar
  3. Matti Davis
    You can also search for this author inPubMed Google Scholar
  4. Iris Lavon
    You can also search for this author inPubMed Google Scholar
  5. Sharon Amit
    You can also search for this author inPubMed Google Scholar
  6. Anthony M. Manning
    You can also search for this author inPubMed Google Scholar
  7. Jens S. Andersen
    You can also search for this author inPubMed Google Scholar
  8. Matthias Mann
    You can also search for this author inPubMed Google Scholar
  9. Frank Mercurio
    You can also search for this author inPubMed Google Scholar
  10. Yinon Ben-Neriah
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toYinon Ben-Neriah.

Rights and permissions

About this article

Cite this article

Yaron, A., Hatzubai, A., Davis, M. et al. Identification of the receptor component of the IκBα–ubiquitin ligase.Nature 396, 590–594 (1998). https://doi.org/10.1038/25159

Download citation